Carna Biosciences (TSE:4572) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Carna Biosciences ROE % Adjusted to Book Value?

Carna Biosciences's ROE % for the quarter that ended in Dec. 2024 was 0.00%. Carna Biosciences's PB Ratio for the quarter that ended in Dec. 2024 was 2.31. Carna Biosciences's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 0.00%.

Carna Biosciences ROE % Adjusted to Book Value Historical Data

The historical data trend for Carna Biosciences's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carna Biosciences ROE % Adjusted to Book Value Chart

Carna Biosciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-7.36

-3.86

-16.71

-13.27

-29.69

Carna Biosciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-10.64	3.48	-18.36	-37.72	-

Competitive Comparison of Carna Biosciences's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Carna Biosciences's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Carna Biosciences's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Carna Biosciences's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Carna Biosciences's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Carna Biosciences ROE % Adjusted to Book Value Calculation

Carna Biosciences's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-68.59%	/	2.31
	=	-29.69%

Carna Biosciences's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	2.31
	=	0.00%

Carna Biosciences ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Carna Biosciences's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Carna Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Carna Biosciences Inc (TSE:4572) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

BMA 3F 1-5-5 Minatojima-Minamimachi, Kobe, JPN, 650-0047

Website

http://www.carnabio.com

Carna Biosciences Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines for the treatment of cancer and inflammatory diseases using own kinase drug discovery platform, QuickScout.

Carna Biosciences Headlines

No Headlines